CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Avita Therapeutics Inc - ADR Company Snapshot
Avita Therapeutics Inc operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Avita Therapeutics Inc with three other companies in this sector in UNITED STATES : Erytech Pharma SA (2019 sales of $5.91 million of which 100% was Pharmacy), Translate Bio Inc ($7.80 million of which 100% was Biological products except diagnostic), and CASI Pharmaceuticals Inc ($4.13 million of which 100% was Innovative Therapeutics - Healthcare & S).

Sales Analysis. Sales increased substantially in 2019: During the year ended June of 2019, sales at Avita Therapeutics Inc were $5.83 million. This is an increase of 339.0% versus 2018, when the company's sales were $1.33 million. This was the third consecutive year of growth at Avita Therapeutics Inc. Sales of Operating-Americas. saw an increase that was more than double the company's growth rate: sales were up 1,166.8% in 2019, from $350,617.71 to $4.44 million. Not all segments of Avita Therapeutics Inc experienced an increase in sales in 2019: sales of Operating-Emea. fell 31.1% to $260,391.01 .
   
   
 
  Stock Performance Chart for Avita Therapeutics Inc - ADR
 
  Stock Data: Recent Stock Performance:
  Current Price (8/7/2020): 24.10
(Figures in U.S. Dollars)
1 Week 10.7%   13 Weeks -11.7%  
4 Weeks -19.4%   52 Weeks -9.1%  
 
Avita Therapeutics Inc - ADR Key Data:
  Ticker: RCEL Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2019 Sales 5,833,529
(Year Ending Jan 2020).
Employees: 87
  Currency: U.S. Dollars Market Cap: 127,577,825
  Fiscal Yr Ends: June Shares Outstanding: 5,293,686
  Share Type: ADR Closely Held Shares: 385,175
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.